Shed is a telehealth weight loss clinic offering compounded semaglutide through an all-inclusive subscription model. The platform delivers medications, coaching, and clinical support 100% online. Shed backs its program with a 10% body weight loss guarantee or a full refund.
The platform stands out for its semaglutide lozenge option — a sublingual delivery format that differs from the standard injectable. Clinical studies confirm semaglutide produces 10-15% body weight reduction when combined with lifestyle changes. Shed packages all components — medication, coaching, telehealth visits, and shipping — into a single subscription fee with no insurance required.
This review covers what Shed includes, how the lozenge delivery works, what real patients report, and whether the 10% guarantee holds up to scrutiny.
What Is Shed?
Shed is a telehealth weight loss clinic that provides compounded semaglutide — including a unique sublingual lozenge format — with health coaching, telehealth visits, and a 10% body weight reduction guarantee. The company positions itself as a simple, safe, and sustainable GLP-1 platform built for patients who want results without complex medical visits. All services are delivered 100% online with no insurance requirement.
Thousands of patients have used Shed’s platform since its launch. The company emphasizes metabolic health alongside weight loss — helping patients reduce sugar intake, improve energy, and build sustainable lifestyle habits alongside medication use.
Shed medications are prepared by partner compounding pharmacies that comply with state regulations and undergo safety and quality inspections. Prescriptions use pharmaceutical-grade ingredients compounded by licensed pharmacists. Orders ship securely, often within days of prescription approval.
What’s included in a Shed all-inclusive program:
- Compounded semaglutide (injection or lozenge)
- Injection or lozenge supplies
- Fast shipping directly to the patient
- Telehealth follow-up appointments
- Access to Care Team support
- Nutrition guidance and health coaching (select plans)
How Does Shed Work?
Shed operates as a fully online telehealth clinic — patients complete a health intake, consult with a licensed provider, receive a prescription, and get medication shipped directly to their door within days of approval. The process eliminates in-person clinic visits. Board-certified physicians review health history and determine clinical eligibility for GLP-1 treatment.
After approval, the personalized health plan is confirmed and medication ships immediately. Patients choose between injectable semaglutide and the sublingual lozenge format depending on their preference and clinical recommendation. The Care Team provides ongoing telehealth follow-ups to monitor progress and adjust dosing.
Shed’s coaching component runs alongside the medication plan. Health coaches offer personalized advice on nutrition, lifestyle modifications, and supplement integration. The coaching is designed to enhance the metabolic effects of semaglutide and build habits that sustain results after treatment.
What Makes Shed Different from Other GLP-1 Platforms?
Shed differentiates itself from competitors through its sublingual semaglutide lozenge format, a 10% body weight guarantee, and a metabolic health focus that extends beyond standard GLP-1 weight loss programs. Most GLP-1 telehealth platforms offer only injectable semaglutide or tirzepatide. Shed’s lozenge option appeals to patients who are needle-averse or prefer oral administration.
The 10% body weight guarantee is a meaningful commitment. Shed offers a full refund if patients do not lose 10% of their body weight on the program. This guarantee reflects confidence in the clinical outcomes of their semaglutide protocol combined with lifestyle support.
The metabolic health framing sets Shed apart from pure weight loss platforms. Shed programs target sugar reduction, improved metabolic markers, and long-term wellness — not just the number on the scale. Patients interested in metabolic health alongside weight loss receive more comprehensive guidance than medication-only services provide.
How Does Shed’s Semaglutide Program Work?
Shed’s program combines compounded semaglutide — delivered as either a weekly injection or daily sublingual lozenge — with coaching and telehealth monitoring to drive weight loss through appetite suppression and improved metabolic function. Semaglutide activates GLP-1 receptors to slow gastric emptying and signal satiety to the brain. The result is reduced hunger and naturally lower caloric intake without deliberate restriction.
Here’s how the approach works in practice: the medication handles the biological side — appetite, blood sugar, metabolic rate. The coaching handles the behavioral side — food choices, meal structure, supplement use. Together, these two components address both drivers of weight regain.
Clinical reviews confirm that combining semaglutide treatment with lifestyle changes produces significant, sustained weight reduction in patients managing obesity or metabolic dysfunction. The Shed model is designed around this evidence — the medication alone produces results, and the coaching amplifies them.
What Is the Semaglutide Lozenge?
The semaglutide lozenge is a sublingual (under-the-tongue) delivery format for compounded semaglutide that dissolves in the mouth rather than requiring a weekly injection — appealing to patients who prefer needle-free administration. Sublingual delivery absorbs semaglutide through the mucous membranes under the tongue directly into the bloodstream. This bypasses the digestive system and avoids first-pass liver metabolism.
The lozenge format is not FDA-approved — it is a compounded formulation developed by Shed’s partner pharmacies. Standard semaglutide products (Ozempic, Wegovy) use subcutaneous injection. The lozenge provides an alternative delivery pathway that compounding pharmacies can produce, though bioavailability data for the sublingual format differs from the established injectable pharmacokinetics.
Patients who switch from injectable GLP-1 programs to Shed often cite the lozenge as their primary reason for choosing the platform. The daily lozenge schedule replaces weekly injection administration. Dosing frequency and clinical outcomes should be discussed with the Shed provider during the initial consultation.
Does Shed Offer Coaching?
Yes. Shed includes health coaching and telehealth-based support as part of its weight loss programs — coaches provide personalized guidance on nutrition, supplement integration, lifestyle modifications, and medication management. Coaching is most comprehensive in select program tiers. Patients should confirm which coaching services are included in their chosen plan during onboarding.
The coaching component addresses metabolic health alongside weight loss. Shed coaches help patients reduce added sugar intake, improve meal quality, and build habits that sustain results after the medication period ends. This behavioral support layer distinguishes Shed from platforms that provide medication delivery without lifestyle guidance.
Shed also offers supplement recommendations tailored to metabolic health goals. Options include supplements supporting energy, sleep quality, and cognitive function. These additions are designed to address the full metabolic picture beyond the appetite suppression and weight loss that semaglutide provides directly.
What Are the Benefits of Shed?
Shed offers a 10% body weight loss guarantee backed by a full refund — a clinical confidence statement that is rare in the GLP-1 telehealth market and reflects the documented efficacy of semaglutide in clinical studies. STEP clinical trials show semaglutide producing 10-15% body weight reduction over 68 weeks. Shed’s guarantee aligns with the lower bound of published clinical evidence.
The all-inclusive pricing model bundles medication, supplies, shipping, coaching, and telehealth into a single subscription. This avoids the surprise billing common with some telehealth platforms that charge separately for consultations, labs, or medication refills.
The lozenge option removes injection anxiety as a barrier to starting GLP-1 treatment. Many patients who research GLP-1 medications delay starting due to fear of self-injection. Shed’s needle-free alternative expands access to a population that would otherwise not pursue GLP-1 treatment.
How Much Weight Can You Lose on Shed?
Shed’s semaglutide program targets a minimum of 10% body weight loss as guaranteed — clinical trials support this outcome with semaglutide producing 10-15% body weight reduction over 68 weeks in the STEP research program. A 200 lb (90.7 kg) person targeting 10% loss would reach a 20 lb (9.1 kg) reduction as the program’s baseline promise. Individual results depend on dose, adherence, diet, and exercise habits.
Patients who engage with Shed’s coaching and nutrition guidance in addition to medication tend to exceed the 10% threshold. The clinical literature confirms that lifestyle modification amplifies semaglutide outcomes. The combination of reduced caloric intake from appetite suppression and structured nutrition coaching produces greater total weight loss than medication alone.
Patients who do not meet the 10% threshold qualify for a refund under Shed’s guarantee terms. The refund policy provides a financial safety net for patients who invest in the program and do not achieve minimum results. Specific terms and conditions of the guarantee should be confirmed during enrollment.
Is Shed Safe?
Yes. Shed uses compounded semaglutide prepared by partner pharmacies that comply with state regulations and undergo safety, quality, and ingredient transparency inspections — and all prescriptions are reviewed by licensed clinicians before dispensing. The clinical oversight model screens for contraindications before medication is approved. Board-certified physicians assess patient health history and determine eligibility individually.
Compounded semaglutide carries the same mechanism-based risk profile as branded Ozempic and Wegovy. Side effects include nausea, vomiting, diarrhea, and a black box warning for thyroid C-cell tumor risk. The FDA does not individually approve compounded formulations — patients should understand that compounded drugs fall outside standard FDA approval while containing the same active ingredient.
The semaglutide lozenge format is unique to compounding platforms like Shed. Standard pharmacokinetic data for injectable semaglutide does not directly apply to sublingual delivery. Patients choosing the lozenge should discuss absorption differences and clinical implications with their Shed provider during the initial consultation.
What Are the Side Effects of Shed’s Medications?
Shed medications carry the standard semaglutide side effect profile — nausea, vomiting, diarrhea, and abdominal discomfort are most common, typically peaking in the first 2-4 weeks of treatment before resolving. These effects are driven by GLP-1’s mechanism of slowing gastric emptying. The delivery format (injection vs. lozenge) may affect the onset and intensity of GI side effects based on absorption rate differences.
Serious adverse events include pancreatitis, thyroid C-cell tumors (black box warning), and potential drug interactions. The Shed clinical screening process identifies patients at elevated risk for serious events before prescribing. Patients with a history of medullary thyroid carcinoma or MEN2 syndrome are excluded as absolute contraindications.
Most patients tolerate semaglutide side effects as manageable and temporary. Dose escalation follows a gradual schedule to allow GI adaptation. Patients who experience severe or persistent side effects contact the Shed Care Team for dose adjustment or plan modification.
Common Shed medication side effects:
- Nausea (most common — 15-25% of patients)
- Vomiting and diarrhea (8-15% of patients)
- Constipation and bloating
- Headache and fatigue in early weeks
- Decreased appetite (expected effect)
Who Should Avoid Shed?
Shed excludes patients with a personal or family history of medullary thyroid carcinoma, MEN2 syndrome, or active pancreatitis — absolute contraindications that the clinical intake process screens for before approving prescriptions. Pregnant patients and those planning pregnancy are not eligible. Semaglutide is not studied in pregnant populations and requires discontinuation before or upon pregnancy discovery.
Patients with severe kidney or liver disease require case-by-case clinical review. These conditions can affect semaglutide metabolism and tolerability. The Shed intake process flags high-risk comorbidities for provider evaluation before approval.
The lozenge option is specifically not appropriate for patients with swallowing disorders, oral lesions, or conditions affecting sublingual absorption. Patients in these categories should discuss the injectable alternative with their provider. Choosing the correct delivery format is part of the initial clinical consultation process.
What Do Shed Reviews Say?
Shed receives positive reviews overall, with patients most frequently citing real weight loss results, the lozenge convenience, and the responsive Care Team as primary satisfaction drivers. The 10% guarantee creates a clear patient expectation and generates confidence in the program before enrollment. Patients who meet or exceed the guarantee threshold leave highly positive reviews.
To be clear: independent reviewers and patients note that coaching depth varies by plan tier. Patients on lower-cost plans receive less 1-on-1 coaching time than those on premium tiers. Setting accurate expectations about coaching access at each price point is important before enrolling.
Review patterns on third-party platforms show consistent praise for the lozenge option and Care Team responsiveness. Negative reviews are a minority and typically involve shipping delays or questions about compounded medication legitimacy. The compounded vs. branded medication distinction is a recurring point of confusion among first-time GLP-1 users.
What Are Positive Shed Experiences?
Positive Shed reviewers most consistently report genuine weight loss results that meet or exceed the 10% guarantee, combined with appreciation for the needle-free lozenge alternative that allowed them to start GLP-1 treatment after avoiding injectables for years. The lozenge converts a significant cohort of needle-averse patients into GLP-1 program participants. This group would not have accessed GLP-1 treatment without the sublingual option.
Patients who engage with the coaching component report faster progress and better lifestyle habit development alongside the medication’s appetite suppression. The combination of reduced hunger from semaglutide and structured eating guidance from coaching produces more comprehensive lifestyle change than medication alone. This pattern appears consistently in five-star reviews.
The all-inclusive pricing model is frequently praised for transparency. Patients appreciate knowing the full program cost upfront without discovering add-on fees for labs, consultations, or refills. The no-insurance-required model also eliminates prior authorization delays that frustrate patients seeking GLP-1 coverage through traditional insurance channels.
What Are Common Shed Complaints?
The most common Shed complaint involves shipping timelines for compounded medications. Compounding pharmacy processing adds variability to delivery schedules. Patients who expect consistent weekly delivery occasionally experience gaps between refill shipments during high-demand periods or pharmacy processing delays.
Some patients question the efficacy of the sublingual lozenge compared to injectable semaglutide. The bioavailability of sublingual semaglutide differs from the established pharmacokinetics of injectable formulations. Patients who switch from branded injectables and notice reduced effects may be experiencing delivery format differences rather than medication quality issues.
Cost remains a concern for patients without HSA or FSA access. Shed’s program is competitively priced compared to branded GLP-1 options but represents a meaningful ongoing expense for patients on tight budgets. Long-term cost commitment is a factor worth evaluating before enrolling, given that weight loss reverses after discontinuation.
How Much Does Shed Cost?
Shed offers an all-inclusive subscription model with medication, supplies, shipping, and care team access bundled together — exact pricing depends on the chosen plan tier and medication type, with no insurance required. The subscription structure avoids per-visit or per-lab fees. Patients pay a predictable monthly rate that covers all core program components.
Patients should confirm current pricing directly with Shed during intake, as rates may vary by medication type (lozenge vs. injectable) and program tier (with or without coaching). The all-inclusive model includes all necessary supplies and shipping costs in the monthly fee.
HSA and FSA funds are applicable toward Shed program costs when prescribed for a medical condition. Medicare and Medicaid are not accepted. Patients with employer health savings accounts should verify eligibility with their plan administrator and obtain documentation from the Shed provider to support reimbursement.
Shed vs. other GLP-1 options:
| Option | Insurance Required | Lozenge Option | Weight Loss Guarantee | Coaching Included |
|---|---|---|---|---|
| Shed | No | Yes | 10% or refund | Yes (select plans) |
| Fridays | No | No | No | Yes (all plans) |
| Branded Ozempic | T2D required | No | No | No |
| Branded Wegovy | Obesity approval | No | No | No |
Is Shed Legit?
Yes. Shed is a legitimate telehealth weight loss clinic using board-certified physicians, licensed compounding pharmacies, and FDA-recognized semaglutide as the active ingredient in its programs. The company is not a scam. Prescriptions require clinical review — medications are not automatically dispensed based on an online form alone.
Compounded semaglutide contains the same active ingredient as Ozempic and Wegovy but is manufactured by compounding pharmacies rather than Novo Nordisk. The FDA does not approve individual compounded formulations, but the active compound is an FDA-recognized ingredient. Patients should understand this distinction before enrolling.
The 10% body weight guarantee reflects genuine confidence in clinical outcomes and backs the program with a financial commitment. Legitimate weight loss programs do not typically offer refund guarantees unless confident in their results. The guarantee functions as a trust signal and differentiates Shed from operators who sell medication without clinical accountability.
Should You Try Eat Proteins with Your Shed Program?
Eat Proteins provides the protein-first nutrition strategy that maximizes what semaglutide starts — appetite suppression from Shed’s program creates the caloric deficit, but protein intake determines whether that deficit burns fat or muscle. GLP-1 medications reduce total caloric intake without differentiating between fat and lean tissue loss. Patients who don’t prioritize protein during treatment often lose a significant proportion of muscle alongside fat.
Our coaches at Eat Proteins work specifically with GLP-1 program patients to build nutrition plans that protect lean mass throughout the medication period. Protein targets, meal timing, and food quality decisions are critical during semaglutide-driven weight loss. The Shed coaching covers lifestyle broadly — Eat Proteins focuses specifically on the protein and muscle preservation layer.
You’ve made the investment in Shed. Protect it with the right nutritional architecture. Combining Shed’s appetite suppression with Eat Proteins’ high-protein guidance turns medication-driven weight loss into targeted fat loss — building the body composition you actually want, not just a lower number on the scale.